Betty Jane Scheihing
Insider
First SEC filing: June 28, 2004 · Latest: June 28, 2004
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 25, 2004 | XRAY | A | 2 | · | · | 2 Direct | · | Acquired | (price as of 2026-10-06) |
| May 5, 2004 | ARW | S | 2,000 | $25.78 | $51,560 | 12,625 Direct | -13.68% | Disposed | 831.8% (price as of 2026-10-05) |
| May 5, 2004 | ARW | S | 4,100 | $25.67 | $105,247 | 14,625 Direct | -21.90% | Disposed | 835.8% (price as of 2026-10-05) |
| May 5, 2004 | ARW | S | 200 | $25.66 | $5,132 | 18,725 Direct | -1.06% | Disposed | 836.2% (price as of 2026-10-05) |
| May 5, 2004 | ARW | S | 475 | $25.65 | $12,184 | 18,925 Direct | -2.45% | Disposed | 836.5% (price as of 2026-10-05) |
| March 25, 2004 | XRAY | A | 3 | · | · | 3 Direct | · | Acquired | (price as of 2026-10-06) |
| Feb. 27, 2004 | ARW | A | 12,000 | · | · | 12,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 25, 2003 | XRAY | A | 216 | $44.08 | $9,521 | 216 Direct | · | Acquired | -60.7% (price as of 2026-10-06) |
| Nov. 14, 2003 | ARW | S | 4,692 | $22.67 | $106,368 | 700 Indirect | -87.02% | Disposed | 959.6% (price as of 2026-10-05) |
| Nov. 14, 2003 | ARW | S | 700 | $22.68 | $15,876 | 0 Indirect | -100.00% | Disposed | 959.2% (price as of 2026-10-05) |
| Nov. 7, 2003 | ARW | M | 25,000 | $17.00 | $425,000 | 59,400 Direct | +72.67% | Acquired | 1313.1% (price as of 2026-10-05) |
| Nov. 7, 2003 | ARW | M | 15,000 | $19.00 | $285,000 | 34,400 Direct | +77.32% | Acquired | 1164.3% (price as of 2026-10-05) |
| Sept. 25, 2003 | XRAY | A | 192 | $44.76 | $8,594 | 192 Direct | · | Acquired | -61.3% (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 25, 2004 | XRAY | Phantom Stock (2Q2004 Deferred Compensation) | Common Stock | $49.47 | · | 2 | Acquired |
| March 25, 2004 | XRAY | Phantom Stock (1Q2004 Deferred Compensation) | Common Stock | $43.94 | · | 3 | Acquired |
| Feb. 27, 2004 | ARW | Employee Benefit Stock Option Plan [F1] | Common Stock | $24.60 | Feb. 27, 2014 | 12,000 | Acquired |
| Dec. 25, 2003 | XRAY | Phantom Stock (4Q2003 Deferred Compensation) | Common Stock | $44.08 | Aug. 8, 1988 | 216 | Acquired |
| Sept. 25, 2003 | XRAY | Phantom Stock (3Q2003 Deferred Compensation) | Common Stock | $44.76 | Aug. 8, 1988 | 192 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).